Biostar Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.34 |
Market Cap |
EUR4.37 M |
Shares Outstanding |
2.64 M |
Public Float |
2.23 M |
Biostar Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.35 |
Market Cap |
$632.75 K |
Shares Outstanding |
2.64 M |
Public Float |
2.21 M |
Address |
No. 588 Shiji Xi Avenue Xianyang Shaanxi 712046 China |
Employees | - |
Website | http://www.biostarpharmaceuticals.com |
Updated | 07/08/2019 |
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. It's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting the Chinese population. The company was founded on March 27, 2007 and is headquartered in Xianyang, China. |